PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 20260 citationsOpen Access

Targeting the endocannabinoid-eicosanoid axis to treat pain: Promise and pitfalls.

View Full Paper
JGJürg Gertsch

Key Points

  • The central aim is to explore the efficacy of A1480LS in alleviating pain through the endocannabinoid-eicosanoid axis.
  • Investigated the effects of diacylglycerol lipase α/β inhibitor A1480LS on pain and inflammation.
  • Analyzed the synthesis of 2-arachidonoylglycerol and its impact on eicosanoid production.
  • Evaluated the consequences on protein kinase C signaling pathways.
  • A1480LS showed potent anti-inflammatory properties in experimental models.
  • Demonstrated significant analgesic effects by reducing eicosanoid levels.
  • Concerns about elevated diacylglycerol effects indicate the need for further safety assessment.

Abstract

In this issue of Cell Chemical Biology, Tufail et al.1 demonstrate that the peripheral diacylglycerol lipase α/β inhibitor A1480LS exerts potent anti-inflammatory and analgesic effects by blocking 2-arachidonoylglycerol synthesis and reducing arachidonate-derived eicosanoid production. However, potential risks from altered protein kinase C signaling due to elevated diacylglycerols warrant further evaluation in future therapeutic applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jürg Gertsch (2026) studied this question.

synapsesocial.com/papers/6974616cbb9d90c67120b4c3https://doi.org/10.48620/94039
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1579 Endocannabinoid biosynthetic enzymes signal through LKB1-AMPK in macrophage inflammation and pain response2024
  2. 2Anandamide as a Therapeutic Target for Alleviating Neuropathic Pain and Inflammation in Rat Models2025 · 8 citations
  3. 3Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia2024 · 2 citations
  4. 4The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy2024 · 4 citations
  5. 5Targeting TLR4-lipid rafts reverses hyper-excitability in pain-associated human dorsal root ganglia2026